Multi-omic molecular comparison of primary versus metastatic pancreatic tumours-Reference-Cited by-同舟云学术

Multi-omic molecular comparison of primary versus metastatic pancreatic tumours

Published:2019-07 Issue:3 Volume:121 Page:264-270
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Brar Gagandeep,Blais Edik M.,Joseph Bender R.,Brody Jonathan R.,Sohal Davendra,Madhavan Subha,Picozzi Vincent J.,Hendifar Andrew E.,Chung Vincent M.,Halverson David,Mikhail Sameh,Matrisian Lynn M.,Rahib Lola,Petricoin Emanuel,Pishvaian Michael J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-019-0507-5.pdf

Reference32 articles.

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA: a Cancer J. Clin. 68, 7–30 (2018).

2. Smith, B. D., Smith, G. L., Hurria, A., Hortobagyi, G. N. & Buchholz, T. A. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J. Clin. Oncol. 27, 2758–2765 (2009).

3. Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M. & Matrisian, L. M. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913–2921 (2014).

4. Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Psarelli, E. E., Valle, J. W., Halloran, C. M. et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 389, 1011–1024 (2017).

5. Sarnecka, A. K., Zagozda, M. & Durlik, M. An Overview of Genetic Changes and Risk of Pancreatic Ductal Adenocarcinoma. J. Cancer. 7, 2045–2051 (2016).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy;Science Advances;2024-07-05

2. Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer;Cellular Oncology;2024-04-15

3. The Clinical Implications of KRAS Mutations and Variant Allele Frequencies in Pancreatic Ductal Adenocarcinoma;Journal of Clinical Medicine;2024-04-04

4. STIM1/SOX2 proteins are co-expressed in the tumor and microenvironmental stromal cells of pancreatic ductal adenocarcinoma and ampullary carcinoma;World Journal of Surgical Oncology;2024-03-26

5. The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients;Nature Cancer;2024-01-22